Market Cap (In EUR)
905.11 Million
Revenue (In EUR)
529.27 Million
Net Income (In EUR)
55.56 Million
Avg. Volume
141.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 76.5-108.99401
- PE
- -
- EPS
- -
- Beta Value
- 0.949
- ISIN
- FR0004186856
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mr. Alain Masson
- Employee Count
- -
- Website
- https://www.vetoquinol.com
- Ipo Date
- 2013-03-05
- Details
- Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
More Stocks
-
MCCX
-
GARAN
-
AAVVFAdvantage Energy Ltd.
AAVVF
-
TDGTDG Gold Corp.
TDG
-
6716
-
MSVB
-
TKRFFTinka Resources Limited
TKRFF
-
9869